2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
MediXall Group Reports Skyrocketed Conversion Rates for Health Karma Social Media Campaigns
Conversion rates more than double industry standards. FORT LAUDERDALE, FL / ACCESSWIRE / April 14, 2021 / MediXall Group, Inc....
Animal Model Market Driven by Developments in Pharmaceutical and CRISPR Genetic Research, Opines Fact.MR
Leading research organizations are investing increasingly in the use of advanced animal models for CRISPR and microinjection applications for long-term...
Jaguar Health and Napo Pharmaceuticals Announce Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Annual Meeting
SAN FRANCISCO, CA / ACCESSWIRE / April 14, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that an abstract associated...
Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532
The substantially improved pharmacological profile of GP532 opens new opportunities for broader therapeutic applications of this class of pharmaceuticals BUFFALO,...
Biotricity to Report Record Revenue Results for Fiscal 2021
Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April 14, 2021 / Biotricity, Inc....
Intellipharmaceutics Announces First Quarter 2021 Results
TORONTO, ON / ACCESSWIRE / April 14, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing...
Alimera Sciences Receives $20 Million From Ocumension Therapeutics
Alimera grants exclusive license to Ocumension for a $10 million upfront payment and up to $89 million in additional sales-based...
Medicenna to Present at the Bloom Burton & Co. Healthcare Investor Conference
TORONTO and HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or “the Company") (NASDAQ: MDNA TSX: MDNA),...
Jushi Holdings Inc. Announces Purchase of Dalitso LLC Facility and Land in Prince William County, VA
Acquisition includes Dalitso’s 93,000 sq. ft. Facility and Nine Acres of Land Positioned to Efficiently Produce a Consistent Supply of...
Wellframe and Validic Form Strategic Collaboration to Enhance Care Management Support with Biometric Monitoring
The alignment allows health plan members to integrate their glucometer devices from the Wellframe app, unlocking a more personalized experience...
Pure Extracts Commences Initial Production Run of 50,000 Gummie Packs for Provincial Distribution
VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
CohBar to Present at the Mitochondria-Targeted Drug Development Summit
MENLO PARK, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Optimi Health Adds to Corporate and Advisory Team
VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or...
Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN8A-DEE
CAMBRIDGE, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...
CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA
BERKELEY HEIGHTS, N.J., April 14, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Agenus Doses First Cancer Patient with iNKT Cell Therapy
LEXINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of...
I-Mab Announces Selected Poster Presentation of CD73 Antibody Uliledlimab at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
SHANGHAI, China., and GAITHERSBURG, MD, April 14, 2021 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company...
Sharps Compliance Announces Third Quarter Fiscal 2021 Conference Call and Webcast
HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that it will release its third...
Homology Medicines Announces Presentations at ACMG Annual Clinical Genetics Meeting
- Data From Company’s PKU and Hunter Syndrome Gene Therapy Programs Featured in Presentations - BEDFORD, Mass., April 14, 2021...
BioCryst Announces Approval of Japanese NHI Price Listing of ORLADEYO™ (berotralstat) for Prophylactic Treatment of Hereditary Angioedema
—ORLADEYO is the first and only approved prophylactic therapy for HAE in Japan— —NHI price listing triggers $15 million milestone...